5-Amino/MIC

• 5-Amino-1MQ: 25 mg
• Methionine: 12.5 mg
• Inositol: 25 mg
• Choline bitartrate: 25 mg
• L-Carnitine: 100 mg

5-Amino/MIC is evaluated as a combined formulation rather than a single active compound. Research suggests its individual components may contribute to the following pathways

• 5-Amino-1MQ: Studied as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in nicotinamide metabolism and cellular methylation balance
• Methionine: Investigated for its role as a methyl-group donor in transmethylation pathways
• Inositol: Explored for its involvement in cellular signaling, membrane dynamics, and metabolic regulation
• Choline bitartrate: Studied as a choline source supporting phospholipid synthesis and one-carbon metabolism
• L-Carnitine: Investigated for its role in fatty-acid transport into mitochondria and cellular energy metabolism

5-Amino/MIC is commonly studied in

• NNMT inhibition and nicotinamide-metabolism research
• Cellular methylation balance and one-carbon-metabolism studies
• Mitochondrial-energy production and fatty-acid-utilization models
• Integrated metabolic-pathway research involving multiple cofactors
• Mechanistic studies examining the relationship between NNMT activity, methyl-donor availability, and metabolic flux

Reported observations are component- and model-dependent and may include

• Gastrointestinal discomfort
• Stimulation-like effects or sleep disruption in sensitive models
• Headache or flushing-like effects in some study paradigms
• Cholinergic-type effects in choline-sensitive systems
• Carnitine-associated odor changes in certain research contexts
• Methylation-related shifts when combined with additional methyl-donor interventions, potentially complicating interpretation of study endpoints

5-Amino/MIC is often explored alongside compounds and variables that support metabolic and methylation-focused research.